Q3 2019 Holdings
Filed 2019-11-14 | 74 holdings | $174.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $123.1M | 1,080,432 | 70.6% |
| Centene Corp del(CNC) | COM | 15135B101 | $35.1M | 810,498 | 20.1% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $13.1M | 424,000 | 7.5% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $242.0K | 3,077,128 | 0.1% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $215.0K | 75,000 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $182.8K | 22,790,134 | 0.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $174.2K | 11,216,809 | 0.1% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $162.3K | 4,780,898 | 0.1% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $155.5K | 8,244,896 | 0.1% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $114.2K | 2,252,600 | 0.1% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $113.8K | 1,162,200 | 0.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $94.9K | 2,410,125 | 0.1% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $89.1K | 8,636,933 | 0.1% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $84.1K | 2,362,486 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $83.2K | 2,962,655 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $68.4K | 1,160,401 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $65.2K | 3,177,760 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $64.1K | 2,077,700 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $63.8K | 4,519,717 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $55.9K | 562,700 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $55.8K | 3,144,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $55.4K | 643,864 | 0.0% |
| Wright MED Group N V | ORD SHS | N96617118 | $49.6K | 2,404,157 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $45.4K | 304,158 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $40.4K | 3,888,752 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $40.1K | 297,972 | 0.0% |
| PRA Health Sciences Inc(PRAH) | COM | 69354M108 | $39.2K | 395,400 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $37.4K | 1,078,300 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $35.4K | 14,616,560 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $33.2K | 923,003 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $30.8K | 2,213,417 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $29.7K | 879,627 | 0.0% |
| Xeris Pharmaceuticals Inc | COM | 98422L107 | $29.5K | 3,000,641 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $28.4K | 235,500 | 0.0% |
| Alder Biopharmaceuticals Inc | NOTE 2.500% 2/0 | 014339AA3 | $27.7K | $25,000,000 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $26.9K | 1,790,288 | 0.0% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $26.8K | 3,104,494 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $26.5K | 1,164,402 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $25.6K | 2,857,389 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $25.3K | 342,987 | 0.0% |
| Genmab A S(GMAB) | SPONSORED ADS | 372303206 | $25.3K | 1,248,600 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $24.0K | 187,599 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $22.3K | 790,006 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $21.9K | 1,017,478 | 0.0% |
| Axonics Modulation Tech Inc(AXNX*) | COM | 05465P101 | $21.8K | 809,700 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $21.4K | 612,558 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $20.1K | 773,571 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $16.0K | 3,115,865 | 0.0% |
| Hookipa Pharma Inc | COM | 43906K100 | $14.2K | 1,897,721 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $14.2K | 3,607,800 | 0.0% |